plerixafor has been researched along with Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YZ; Luo, Q; Piao, JM; Wu, W; Yang, ZX; Yu, JL | 1 |
| Chen, SC; He, QW; Hu, B; Huang, M; Huang, Y; Li, YN; Mao, L; Wang, MD; Xia, YP; Zheng, L | 1 |
| He, X; Huang, J; Li, Y; Lin, X; Liu, Y; Lu, Y; Tang, G; Tang, YH; Wang, Y; Yang, GY | 1 |
| He, QW; Hu, B; Huang, M; Jin, HJ; Li, M; Li, YN; Mao, L; Wan, Y; Xia, YP | 1 |
| Chen, Y; Fan, Y; Frenzel, T; Liu, J; Shen, F; Su, H; Yang, GY; Ye, J; Young, WL; Zhu, W | 1 |
5 other study(ies) available for plerixafor and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
MicroRNA-381 Favors Repair of Nerve Injury Through Regulation of the SDF-1/CXCR4 Signaling Pathway via LRRC4 in Acute Cerebral Ischemia after Cerebral Lymphatic Blockage.
Topics: Animals; Benzylamines; Brain Ischemia; Chemokine CXCL12; Cyclams; Disease Models, Animal; Down-Regulation; Heterocyclic Compounds; Hippocampus; Infarction, Middle Cerebral Artery; Interleukin-1beta; Leucine-Rich Repeat Proteins; Male; MicroRNAs; Mitogen-Activated Protein Kinase 3; Proteins; Rats; Rats, Wistar; Receptors, CXCR4; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2018 |
Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Endothelial Progenitor Cells; Heterocyclic Compounds; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptors, CXCR4; Severity of Illness Index; Stroke | 2014 |
Postacute stromal cell-derived factor-1α expression promotes neurovascular recovery in ischemic mice.
Topics: Animals; Anti-HIV Agents; Behavior, Animal; Benzylamines; Chemokine CXCL12; Cyclams; Dependovirus; Doublecortin Protein; Gene Expression Regulation; Genetic Therapy; Heterocyclic Compounds; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Neurogenesis; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Receptors, CXCR4 | 2014 |
Inhibiting the Migration of M1 Microglia at Hyperacute Period Could Improve Outcome of tMCAO Rats.
Topics: Animals; Animals, Newborn; Anti-HIV Agents; Benzylamines; Brain Infarction; Cell Hypoxia; Cell Movement; Cell Polarity; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Cyclams; Cytokines; Disease Models, Animal; Heterocyclic Compounds; Infarction, Middle Cerebral Artery; Male; Microglia; Neurons; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley | 2017 |
Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.
Topics: Analysis of Variance; Animals; Antigens, CD34; Behavior, Animal; Benzylamines; Cadherins; Capillaries; CD11b Antigen; Cerebral Infarction; Chemokine CXCL12; Cyclams; Disease Models, Animal; Endothelial Cells; Endothelium; Flow Cytometry; Gene Expression Regulation; Heterocyclic Compounds; Humans; Infarction, Middle Cerebral Artery; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Mice, Nude; Motor Activity; Neovascularization, Physiologic; Psychomotor Performance; Receptors, CXCR4; Stem Cell Transplantation; Time Factors; Vascular Endothelial Growth Factor Receptor-2; von Willebrand Factor | 2010 |